Wee1 kinase as a target for cancer therapy
Open Access
- 29 October 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in Cell Cycle
- Vol. 12 (19), 3348-3353
- https://doi.org/10.4161/cc.26062
Abstract
Wee1, a protein kinase, regulates the G 2 checkpoint in response to DNA damage. Preclinical studies have elucidated the role of wee1 in DNA damage repair and the stabilization of replication forks, supporting the validity of wee1 inhibition as a viable therapeutic target in cancer. MK-1775, a selective and potent small-molecule inhibitor of wee1, is under clinical development as a potentiator of DNA damage caused by cytotoxic chemotherapies. We present a review of the role of wee1 in the cell cycle and DNA replication and summarize the clinical development to date of this novel class of anticancer agents.Keywords
This publication has 41 references indexed in Scilit:
- Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonucleaseThe Journal of cell biology, 2011
- Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibitionNature Medicine, 2011
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer XenograftsClinical Cancer Research, 2011
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in GlioblastomaCancer Cell, 2010
- Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phaseThe Journal of cell biology, 2010
- Swe1Wee1-Dependent Tyrosine Phosphorylation of Hsp90 Regulates Distinct Facets of Chaperone FunctionMolecular Cell, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinomeBreast Cancer Research and Treatment, 2009
- Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA DamageMolecular Cell, 2009
- PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathwaysNucleic Acids Research, 2006